Clinical Trials
22 trialsReal-Time IGRT
University of Sydney
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
National Cancer Institute (NCI)
PREDU
University of Vic - Central University of Catalonia
A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
QVA-Mod
Hospices Civils de Lyon
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
PEPOH
University of Salamanca
IMRD
European Institute of Oncology
Immune Cell Therapy for Advanced Solid Tumors
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
Novartis
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
Shanghai Bao Pharmaceuticals Co., Ltd.
CorTox
Technische Universität Dresden
Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
FAST-CR
The University of Hong Kong-Shenzhen Hospital
FUTURE
Assistance Publique Hopitaux De Marseille
SOMEST'ALIM2
Hospices Civils de Lyon
VCV
Mitera Hospital
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Myeloprotection With Trilaciclib in Pan-cancer Population
Sun Yat-sen University
CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
Convalife (Shanghai) Co., Ltd.